← Back to Clinical Trials
Recruiting NCT07302672

NCT07302672 Humanistic Continuing Care Via WeChat for Patients Undergoing Thermal Ablation of Papillary Thyroid Carcinoma

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07302672
Status Recruiting
Phase
Sponsor Ming-an Yu
Condition Papillary Thyroid Carcinoma
Study Type INTERVENTIONAL
Enrollment 108 participants
Start Date 2025-12-15
Primary Completion 2026-06-30

Trial Parameters

Condition Papillary Thyroid Carcinoma
Sponsor Ming-an Yu
Study Type INTERVENTIONAL
Phase N/A
Enrollment 108
Sex ALL
Min Age 16 Years
Max Age 60 Years
Start Date 2025-12-15
Completion 2026-06-30
Interventions
Humanistic Continuing Care via WeChatUsual Care (No Structured WeChat Program)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The goal of this clinical trial is to test whether human-centered nursing care lowers emotional distress and improves quality of life for people who are awake during thyroid thermal ablation. The procedure uses local anesthesia, so participants remain awake and may feel tense. Human-centered care focuses on emotional support, clear communication, comfort, and follow-up, and it may improve the experience and recovery for patients. The main questions are: Does human-centered nursing care reduce emotional distress levels in patients undergoing thyroid thermal ablation? Does human-centered nursing care improve patient quality of life after thyroid thermal ablation? If there is a comparison group: Researchers will compare human-centered nursing care to usual nursing care to see if human-centered care leads to lower emotional distress and higher quality of life. Participants will: Receive either human-centered nursing care or usual nursing care. Complete questionnaires before, during, and after the procedure to measure emotional distress, quality of life, pain, and satisfaction with care. Have their vital signs and quality of life tracked during and after the procedure. Have their adherence to care plans and any complications monitored. The main outcomes are emotional distress levels and quality of life. Other outcomes include pain and vital signs during the procedure, satisfaction with care, and complication rates. Results may guide better care for people undergoing small, minimally invasive treatments while awake.

Eligibility Criteria

Inclusion Criteria: * Age 16-60 years; scheduled for thyroid thermal ablation * Papillary thyroid carcinoma (PTC) * Number of target lesions \<= 3 * Largest lesion diameter \<= 2 cm; clinical stage T1N0M0 by imaging * Awake and able to cooperate under local anesthesia Owns a smartphone and can use WeChat Exclusion Criteria: * Serious medical comorbidities or cognitive impairment that precludes participation * Prior thyroid surgery or thermal ablation * Unwilling or unable to join the WeChat group or complete postoperative follow-up

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology